2021

2020

2019

Product sales, net:

ORLADEYO

$

121,865

$

133

$

−

RAPIVAB

7,231

483

13,864

Peramivir

7,254

2,685

3,669

Total product sales, net

136,350

3,301

17,533

Royalty revenue

(100

)

3,381

6,303

Milestone revenue

15,000

−

Collaborative and other research and development revenues:

U.S. Department of Health and Human Services

5,920

9,231

4,898

Torii Pharmaceutical Co., Ltd.

−

1,899

20,101

Total collaborative and other research and development revenues

5,920

11,130

24,999

Total revenues

$

157,170

$

17,812

$

48,835